Skip Navigation

A Phase I Open-Label, Multi-Center Study of PSMA Targeted Genetically Modified Chimeric Antigen Receptor T Cells in Patients with Metastatic Castration Resistant Prostate Cancer

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT04227275

Study #:
STUDY00145790

Start Date:
Dec 14, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04227275

View Complete Trial Details & Eligibility at ClinicalTrials.gov